Delivery system design for improvement of intestinal absorption of peptide drugs

Yakugaku Zasshi

Volumn 117, Issue 7, 1997, Pages 394-414

  Muranishi, Shozo ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Absorption enhancer; Acylation; Carrier mediated transport; Chemical modification; Lymphatic targeting; Passive diffusion

Indexed keywords

DEXTRAN SULFATE; PEPTIDE HORMONE;

ACYLATION; CELL MEMBRANE PERMEABILITY; CHEMICAL MODIFICATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG STABILITY; ENHANCER REGION; GENE TARGETING; INTESTINE ABSORPTION; MOLECULAR INTERACTION; NONHUMAN; PASSIVE TRANSPORT; PHOSPHOLIPID MEMBRANE; REVIEW;

EID: 0030840888     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi1947.117.7_394     Document Type: Review

References (72)

1. Davis S. S., "Delivery Systems for Peptide Drugs," eds. by Davis S. S., Ilum L., Thomlinson E., Plenum Press, New York, 1986, p. 1.
2. Lee V.H.L., Yamamoto A., Adv. Drug Deliv. Rev., 4, 171 (1990).
3. Engel R. H., Riggi S. J., Proc Soc. Exp. Biol. Med., 130, 879 (1969).
4. Tidball C. S., Proc Soc. Exp. Biol. Med., 111, 713 (1962).
5. Muranishi S., Tokunaga Y., Taniguchi K., Sezaki H., Chem. Pharm. Bull., 25, 1159 (1977).
6. Tokunaga Y., Muranishi S., Sezaki H., J. Pharmacobio-Dyn., 1, 28 (1978).
7. Taniguchi K., Muranishi S., Sezaki H., Int. J. Pharm., 4, 219 (1980).
8. Muranushi N., Kinugawa M., Nakajima Y., Muranishi S., Sezaki H., Int. J. Pharm., 4, 271 (1980).
9. Muranushi N., Nakajima Y., Kinugawa M., Muranishi S., Sezaki H., Int. J. Pharm., 4, 281 (1980).
10. Muranishi S., "Rectal Therapy," eds. by Glaus B., de Blaey C. J., J. R. Prous Publishers, Barcelona, 1984, p. 35.
11. Nishihata T., Rytting J. H., Higuchi T., Caldwell L., J. Pharm. Pharmacol., 33, 334 (1981).
12. Nishihata T., Rytting J. H., Kamada A., Higuchi T., Diabetes, 30, 1065 (1981).
13. Nishimura K., Nozaki Y., Yoshimi A., Nakamura S., Kitagawa M., Kakeya N., Kitao K., Chem. Pharm. Bull., 33, 282 (1985).
14. Sekine M., Sasahara K., Kojima T., Hasegawa K., Okada R., Chem. Pharm. Bull., 32, 4189 (1984).
15. Murakami T., Tamauchi H., Yamazaki M., Kubo K., Kamada A., Yata N., Chem. Pharm. Bull., 29, 1986 (1981).
16. Fix J. A., Engle K., Porter P. A., Leppert P. S., Selk S. J., Gardner C. R., Alexander J., Am. J. Physiol., 251, G332 (1986).
17. Murakami M., Kusanoi Y., Takada K., Muranishi S., Int. J. Pharm., 79, 159 (1992).
18. Ziv E, Kidron M., Berry E. M., Bar-On H., Life Sci., 29, 803 (1981).
19. Van Hoogdalem E. J., Heijligers-Feijen C. D., Mathot R.A.A., Wackwitz A.T.E., van Bree J.B.M.M., Verhoef J. C., de Boer A. G., Breimer D. D., J. Pharmacol. Exp. Ther., 251, 741 (1989).
20. Murakami M., Takada K., Muranishi S., Int. J. Pharm., 31, 231 (1986).
21. Fukui H., Murakami M., Takada K., Muranishi S., Int. J. Pharm., 31, 239 (1986).
22. Kastin A. J., Animura A., Schally A. V., Arch. Derm., 93, 471 (1966).
23. Munro D. D., Stoughton R. B., Arch. Derm., 92, 585 (1965).
24. Caldwell L., Nishihata T., Fix J., Selk S., Cargill R., Gardner C. R., Higuchi T., "Rectal Therapy," eds. by Glaus B., de Blaey C. J., J. R. Prous Publishers, Barcelona, 1984, p. 57.
25. Muranishi S., "Topics in Pharmaceutical Sciences," eds. by Breimer D. D., Speiser P., Elseiver Science Publishers, Ansterdam, 1987, p. 445.
26. Muranishi S., Pharm. Res., 2, 108 (1985).
27. Muranishi S., Crit. Rev. Ther. Drug Carrier Syst., 7, 1 (1990).
28. Masuda Y., Yoshikawa H., Takada K., Muranishi S., J. Pharmacobio-Dyn., 9, 793 (1986).
29. Muranushi N., Takagi N., Muranishi S., Sezaki H., Chem. Phys. Lipids, 28, 269 (1981).
30. Goodman M., Barry B. W., J. Pharm. Pharmacol., 37 (Suppl.), 80P (1985).
31. Goodman M., Barry B. W., J. Pharm. Pharmacol., 38 (Suppl.), 71 P (1986).
32. Murakami M., Takada K., Muranishi S., J. Pharmacobio-Dyn., 10, s-136 (1987).
33. Muranishi S., "Nobel Drug Delivery," eds. by Prescott L. F., Nimmo W. S., John Wiley & Sons, Ldt., New York, 1989, p. 69.
34. Murakami M., Takada K., Fujii T., Muranishi S., Biochim. Biophys. Acta, 939, 238 (1988).
35. Murakami M., Takada K., Muranishi S., Biochim. Biophys. Acta, 1117, 83 (1992).
36. Muranishi S., Murakami M., "Topics in Pharmaceutical Sciences 1991," eds. by Crommelin D. J. A., Midha K. K., Medpharm Scientic Publishers, Stuttgart, 1992, p. 139.
37. Tomita M., Hayashi M., Horie T., Ishizawa T., Awazu S., Pharm. Res., 5, 786 (1988).
38. Muranishi S., Takada K., Yoshikawa H., Murakami M., "Delivery System for Peptide Drugs," eds. by Davis S. S., Ilum L., Tomlinson E., Plenum Press, New York, 1986, p. 177.
39. Noach A. B. J., Hurni M. A., de Boer A. G., Breimer D., "Drug Absorption Enhancement: Concepts, Possibilities, Limitations and Trends," ed. by De Boer A. G., Harwood Academic Publishers, Poststrasse, 1994, p. 291.
40. Madara J. L., Moore R., Carlson S., Am. J. Physiol., 253, C854 (1987).
41. Murakami M., Muranishi S., J. Pharmacobio-Dyn., 15, s-27 (1992).
42. Tomita M., Hayashi M., Awazu S., J. Pharm. Exp. Ther., 272, 739 (1995).
43. Tomita M., Hayashi M., Awazu S., J. Pharm. Sci., 85, 608 (1996).
44. Anderberg, E. K., Lindmark T., Artursson P., Pharm. Res., 10, 857 (1993).
45. Yoffey J. M., Courtice F. C., "Lymphatics, Lymph and the Lymphomyeloid Complex," Academic Press, London, 1970.
46. Takahashi T., Crit. Rev. Ther. Drug Carrier Syst., 2, 245 (1986).
47. Sieber S. M., Chon V. H., Wynn W. T., Xenobiotica, 4, 265 (1974).
48. Yoshikawa H., Muranishi S., Kato C., Sezaki H., Int. J. Pharm., 8, 291 (1981).
49. Yoshikawa H., Takada K., Muranishi S., Pharm. Res., 9, 1190 (1992).
50. Yoshikawa H., Sezaki H., Muranishi S., Int. J. Pharm., 13, 321 (1983).
51. Yoshikawa H., Takada K., Muranishi S., Chem. Pharm. Bull., 31, 4070 (1983).
52. Yoshikawa H., Takada K., Satoh Y., Naruse N., Muranishi S., Pharm. Res., 2, 249 (1985).
53. Yoshikawa H., Takada K., Satoh Y., Naruse N., Muranishi S., Pharm. Res., 3, 116 (1986).
54. Muranishi S., Adv. Drug Res., 21, 1 (1991).
55. Hanatani K., Takada K., Yoshida N., Nakasuji M., Morishita Y., Yasako K., Fujita T., Yamamoto A., Muranishi S., J. Drug Targeting, 3, 263 (1995).
56. Muranishi S., Murakami M., Hashizume M., Yamada K., Tajima S., Kiso Y., J. Controlled Release, 19, 179 (1992).
57. Ueda C. T., Lemire M., Misslin P., Biopharm. Drug Disp., 4, 83 (1983).
58. Takada K., Yoshimura H., Sibata N., Masuda Y., Yoshikawa H., Muranishi S., Yasumura T., Oka J., J. Pharmacobio-Dyn., 9, 156 (1986).
59. S. Muranishi, Sakai A., Yamada K., Murakami M., Takada K., Kiso Y., Pharm. Res., 8, 649 (1991).
60. Tenma T., Yodoya E., Tashima S., Fujita T., Murakami M., Yamamoto A., Muranishi S., Pharm. Res., 10, 1488 (1993).
61. Fujita T., Fujita T., Morikawa K., Tanaka H., Iemura O., Yamamoto A., Muranishi S., Int. J. Pharm., 134, 47 (1996).
62. Hashimoto M., Takada K., Kiso Y., Muranishi S., Pharm. Res., 6, 171 (1989).
63. Hashizume M., Douen T., Murakami M., Yamamoto A., Takada K., Muranishi S., J. Pharm. Pharmacol., 44, 555 (1992).
64. Asada H., Douen T., Mizokoshi Y., Fujita T., Murakami M., Yamamoto A., Muranishi S., Pharm. Res., 11, 1115 (1994).
65. Yokohama S., Yoshioka T., Yamashita K., Kitamori N., , J. Pharmacobio-Dyn., 7, (1984).
66. Yamada K., Murakami M., Yamamoto A., Takada K., Muranishi S., J. Pharm. Pharmacol., 44, 717 (1992).
67. Tanaka K., Fujita T., Yamamoto Y., Murakami M., Yamamoto A., Muranishi S., Biochim. Biophys. Acta, 1283, 119 (1996).
68. Yamamoto A., Muranishi S., Drug Deliv. Syst., in press (1997).
69. Yodoya E., Uemura K., Tenma T., Fujita T., Murakami M., Yamamoto A., Muranishi S., J. Pharmacol. Exp. Ther., 271, 1509 (1994).
70. Asada H., Douen T., Waki M., Adachi S., Fujita T., Yamamoto A., Muranishi S., J. Pharm. Sci., 84, 682 (1995).
71. Kawahara I., Fujita T., Hattori K., Takenaka K., Yamamoto A., Muranishi S., submitted (1997).